New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich Plasma
Pain in the attachment of the plantar fascia in the calcaneus represents 10% of all sports injuries, affects 10% of foot runners, and will affect around 20% of the world population. There is no effective conservative treatment for it. This paper justifies a new definition and name for this pathology...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-12-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/13/1/170 |
| _version_ | 1797358590295539712 |
|---|---|
| author | Francesc Pardo-Camps Francesc Pardo-Bosch |
| author_facet | Francesc Pardo-Camps Francesc Pardo-Bosch |
| author_sort | Francesc Pardo-Camps |
| collection | DOAJ |
| description | Pain in the attachment of the plantar fascia in the calcaneus represents 10% of all sports injuries, affects 10% of foot runners, and will affect around 20% of the world population. There is no effective conservative treatment for it. This paper justifies a new definition and name for this pathology, Plantar Fascia Syndrome (PFS), presents a methodology for its diagnosis, and presents the clinical and functional effectiveness of a new conservative treatment based on platelet-rich plasma (PRP). In total, 25 patients (from an initial sample of 260) diagnosed with recalcitrant PFS lasting for more than 12 months were treated with a single infiltration of 2 mL of PRP, according to a new technic proposed. The study was approved by the ethical committee for clinical research of the reference hospital. The patients were controlled after 15, 30, 90, and 180 days, reviewing on each occasion pain, thickness of the plantar fascia, and active extension of the ankle joint. A total of 15 days after infiltration, 85% of patients had no clinical signs requiring treatment. After 90 days of infiltration, no patients showed clinical signs. This improvement in the patients’ condition lasted for 180 days. All patients after treatment can fully resume normal activity with no pain. |
| first_indexed | 2024-03-08T15:03:17Z |
| format | Article |
| id | doaj.art-5349e6979ead4e41b87e431aae69efd9 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-08T15:03:17Z |
| publishDate | 2023-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-5349e6979ead4e41b87e431aae69efd92024-01-10T15:01:25ZengMDPI AGJournal of Clinical Medicine2077-03832023-12-0113117010.3390/jcm13010170New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich PlasmaFrancesc Pardo-Camps0Francesc Pardo-Bosch1University Clinic, Complutense University of Madrid, Plaza Ramón y Cajal, s/n, 28040 Madrid, SpainDepartament of Project and Construction Engineering, Universitat Politècnica de Catalunya (BarcelonaTech), C. Jordi Girona 1-3, 08034 Barcelona, SpainPain in the attachment of the plantar fascia in the calcaneus represents 10% of all sports injuries, affects 10% of foot runners, and will affect around 20% of the world population. There is no effective conservative treatment for it. This paper justifies a new definition and name for this pathology, Plantar Fascia Syndrome (PFS), presents a methodology for its diagnosis, and presents the clinical and functional effectiveness of a new conservative treatment based on platelet-rich plasma (PRP). In total, 25 patients (from an initial sample of 260) diagnosed with recalcitrant PFS lasting for more than 12 months were treated with a single infiltration of 2 mL of PRP, according to a new technic proposed. The study was approved by the ethical committee for clinical research of the reference hospital. The patients were controlled after 15, 30, 90, and 180 days, reviewing on each occasion pain, thickness of the plantar fascia, and active extension of the ankle joint. A total of 15 days after infiltration, 85% of patients had no clinical signs requiring treatment. After 90 days of infiltration, no patients showed clinical signs. This improvement in the patients’ condition lasted for 180 days. All patients after treatment can fully resume normal activity with no pain.https://www.mdpi.com/2077-0383/13/1/170platelet-rich plasmaPRPinfiltrationplantar fascia syndromeconservative treatment |
| spellingShingle | Francesc Pardo-Camps Francesc Pardo-Bosch New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich Plasma Journal of Clinical Medicine platelet-rich plasma PRP infiltration plantar fascia syndrome conservative treatment |
| title | New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich Plasma |
| title_full | New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich Plasma |
| title_fullStr | New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich Plasma |
| title_full_unstemmed | New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich Plasma |
| title_short | New Infiltration Technique in the Treatment of the Plantar Fascia Syndrome Based on Platelet-Rich Plasma |
| title_sort | new infiltration technique in the treatment of the plantar fascia syndrome based on platelet rich plasma |
| topic | platelet-rich plasma PRP infiltration plantar fascia syndrome conservative treatment |
| url | https://www.mdpi.com/2077-0383/13/1/170 |
| work_keys_str_mv | AT francescpardocamps newinfiltrationtechniqueinthetreatmentoftheplantarfasciasyndromebasedonplateletrichplasma AT francescpardobosch newinfiltrationtechniqueinthetreatmentoftheplantarfasciasyndromebasedonplateletrichplasma |